Viewing Study NCT04908956


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-01-02 @ 12:13 PM
Study NCT ID: NCT04908956
Status: TERMINATED
Last Update Posted: 2024-06-28
First Post: 2021-05-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Osimertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR Mutant NSCLC (STEREO)
Sponsor: ETOP IBCSG Partners Foundation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module